PBSV vs JNJ: Which Stock is Better?

Side-by-side comparison of Pharma-Bio Serv, Inc. and Johnson & Johnson in 2026

Comparison Updated:

PBSV

Pharma-Bio Serv, Inc.

$0.50

JNJ

Johnson & Johnson

$234.18

Key Metrics Comparison

MetricPBSVJNJWinner
Market Cap$11.45M$565.22BJNJ
P/E RatioN/A21.26JNJ
EPS (TTM)$N/A$11.03JNJ
Revenue Growth-0.1%0.1%JNJ
Gross Margin32.5%68.0%JNJ

Analyze PBSV

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is PBSV or JNJ a better investment?

Comparing PBSV and JNJ: Pharma-Bio Serv, Inc. has a market cap of $11.45M while Johnson & Johnson has $565.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between PBSV and JNJ?

PBSV (Pharma-Bio Serv, Inc.) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: PBSV or JNJ?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: PBSV or JNJ?

JNJ has higher revenue growth at 0.1% vs -0.1% for PBSV.

Which company is more profitable: PBSV or JNJ?

Johnson & Johnson (JNJ) has higher gross margins at 68.0% compared to 32.5% for PBSV.

Which is the larger company: PBSV or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $565.22B compared to $11.45M for PBSV.

Should I buy PBSV or JNJ in 2026?

Both PBSV and JNJ have investment merit. PBSV trades at $0.50 while JNJ trades at $234.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between PBSV and JNJ stock?

Key differences: Market Cap ($11.45M vs $565.22B), P/E Ratio (N/A vs 21.3x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (32.5% vs 68.0%).

Popular Stock Comparisons